Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer
Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high mortality rates. Several clinical trials and meta-analyses have determined that the use of pharmacological inhibitors of cyclooxygenase 2 (COX-2), the enzyme that catalyses the rate-limiting step in the synthe...
Saved in:
Main Authors: | Alicia M. Hidalgo-Estévez (Author), Konstantinos Stamatakis (Author), Marta Jiménez-Martínez (Author), Ricardo López-Pérez (Author), Manuel Fresno (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cyclooxygenase 2 Effector Genes as Potential Inflammation-Related Biomarkers for Colorectal Cancer Circulating Tumor Cells Detection by Liquid Biopsy
by: Konstantinos Stamatakis, et al.
Published: (2022) -
Unveiling ferroptosis as a promising therapeutic avenue for colorectal cancer and colitis treatment
by: Aaron T. Kao, et al.
Published: (2024) -
Interaction of Signaling Lymphocytic Activation Molecule Family 1 (SLAMF1) receptor with Trypanosoma cruzi is strain-dependent and affects NADPH oxidase expression and activity.
by: Cristina Poveda, et al.
Published: (2020) -
Cyclooxygenase-2 and Prostaglandin E2 Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection.
by: Néstor A Guerrero, et al.
Published: (2015) -
Correction: Cyclooxygenase-2 and Prostaglandin E2 Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection.
by: Néstor A Guerrero, et al.
Published: (2015)